{
    "2021-11-29": [
        [
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：持股5%以上的曹晓春解押260万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "曹晓春",
                        "解押",
                        "260万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：OMICRON成热议 CDMO和上游边际改善",
                "features": {
                    "keywords": [
                        "医药行业",
                        "OMICRON",
                        "CDMO",
                        "上游边际改善"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药荣获弗若斯特沙利文“2021中国临床CRO竞争战略领导力奖”",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "弗若斯特沙利文",
                        "CRO",
                        "领导力奖"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英赴港IPO：背后那起让高瓴资本很受伤的A股定增",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "赴港IPO",
                        "高瓴资本",
                        "A股定增"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)持股5%以上股东部分股份回购并解除质押",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "股东",
                        "回购",
                        "解除质押"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)主要股东曹晓春解除质押260万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "曹晓春",
                        "解除质押",
                        "260万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}